Frontier Biotechnologies (SHSE:688221) Institutional Ownership: 14.53% (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688221 Frontier Biotechnologies Inc SHSE:688221
67 GF Score
Price ¥18.84
GF Value ¥37.71
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Frontier Biotechnologies Institutional Ownership?

Frontier Biotechnologies SHSE:688221 -3.53% 67 Institutional Ownership is 14.53% as of Aug. 30, 2026. GuruFocus rates SHSE:688221 with a GF Score™ of 67/100 and a GF Value™ of ¥37.71 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Frontier Biotechnologies's institutional ownership is 14.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Frontier Biotechnologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Frontier Biotechnologies's Float Percentage Of Total Shares Outstanding is 0.00%.

Frontier Biotechnologies Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Frontier Biotechnologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontier Biotechnologies Institutional Ownership Chart

Frontier Biotechnologies Historical Data

The historical data trend for Frontier Biotechnologies can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 2.09 2.09 14.53 14.53 14.53 14.53 14.53 14.53 14.53 14.53
SHSE:688221
67GF Score
Frontier Biotechnologies Inc SHSE:688221
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Frontier Biotechnologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 14.53% mean?
Frontier Biotechnologies (SHSE:688221) has a Institutional Ownership of 14.53% as of Aug. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Frontier Biotechnologies and its competitors.
Is Frontier Biotechnologies' Institutional Ownership too high?
Frontier Biotechnologies' current Institutional Ownership is 14.53%. Overall, Frontier Biotechnologies has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Frontier Biotechnologies' Institutional Ownership compare to ZTS?
Frontier Biotechnologies' Institutional Ownership of 14.53% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Frontier Biotechnologies and its competitors. Frontier Biotechnologies's current Institutional Ownership is 14.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontier Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, Frontier Biotechnologies (SHSE:688221) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥37.71, compared to a current price of ¥18.84 — trading 50% below its estimated fair value. The current Institutional Ownership is 14.53%. Frontier Biotechnologies' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Frontier Biotechnologies (SHSE:688221), the current Institutional Ownership is 14.53% as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Frontier Biotechnologies (SHSE:688221) Overvalued in 2026?

Based on GuruFocus' analysis, Frontier Biotechnologies stock appears to be undervalued. The current stock price of ¥18.84 is trading 50% below its estimated GF Value™ of ¥37.71. GuruFocus considers Frontier Biotechnologies to be Significantly Undervalued.

Key valuation signals for SHSE:688221:

  • Institutional Ownership: 14.53%
  • GF Value™: ¥37.71 vs. price of ¥18.84 (50% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688221 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Frontier Biotechnologies Business Description

Address Dongshan Street, 11th Floor, Building E-2, Greenland Window, Jiangning District, Jiangsu Province, Nanjing, CHN, 211199
Frontier Biotechnologies Inc is engaged in the Research, development, production, and marketing of inventive drugs that address unmet clinical needs.
67GF Score

Get the complete analysis for SHSE:688221

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.84
Price
¥37.71
GF Value